Conjoint Analysis of a New Chemotherapy: Willingness to Pay and Preference for the Features of Raltitrexed versus Standard Therapy in Advanced Colorectal Cancer

Author： Aristides M.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.20, Iss.11, 2002-01, pp. : 775-784

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

WTP high for raltitrexed vs standard therapy in colorectal cancer

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 380, 2002-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

WTP high for raltitrexed vs standard therapy in colorectal cancer

By  

Inpharma, Vol. 1, Iss. 1355, 2002-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer

By Cao Shousong   Bhattacharya Arup   Durrani Farukh A   Fakih Marwan  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. : 687-703

Informa Healthcare

Access to resources Recommend Favorite

Costs Incurred by Patients Undergoing Advanced Colorectal Cancer Therapy: A Comparison of Raltitrexed and Fluorouracil plus Folinic Acid

By Sculpher M.  

PharmacoEconomics, Vol. 17, Iss. 4, 2000-04 ,pp. : 361-370

Adis International

Access to resources Recommend Favorite

Conjoint Analysis of French and German Parents' Willingness to Pay for Meningococcal Vaccine

By Bishai David  

PharmacoEconomics, Vol. 25, Iss. 2, 2007-01 ,pp. : 143-154

Adis International

Access to resources Recommend Favorite